Atlas Trials

Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis

Clinical trial NCT04129736 · COMPLETED

Trial details

NCT number
NCT04129736
Sponsor
Jan Lycke
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis, Pharmacokinetics
Start date
2019-10-10
Primary completion
2021-03-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.